{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:44:30Z","timestamp":1791027870215,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.05.021","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T15:45:33Z","timestamp":1212507933000},"page":"4025-4033","source":"Crossref","is-referenced-by-count":19,"title":["Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens"],"prefix":"10.1016","volume":"26","author":[{"given":"Alain","family":"Luxembourg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bud C.","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"74","key":"10.1016\/j.vaccine.2008.05.021_bib1","first-page":"545","article-title":"Hepatitis B today","volume":"54","author":"Safioleas","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.vaccine.2008.05.021_bib3","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3748\/wjg.v13.i18.2554","article-title":"Future prospectives for the management of chronic hepatitis B","volume":"13","author":"Leemans","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.021_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/14728214.12.2.199","article-title":"Emerging drugs for hepatitis B","volume":"12","author":"Zoulim","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.021_bib5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.181.3.1047","article-title":"The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis","volume":"181","author":"Rehermann","year":"1995","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.021_bib7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1172\/JCI119308","article-title":"Cytotoxic T cells and viral hepatitis","volume":"99","author":"Chisari","year":"1997","journal-title":"J Clin Invest"},{"issue":"4 Part 1","key":"10.1016\/j.vaccine.2008.05.021_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/jhep.2000.17681","article-title":"Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection","volume":"32","author":"Cote","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.021_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1128\/JVI.76.4.1769-1780.2002","article-title":"Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation","volume":"76","author":"Menne","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.021_bib10","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1128\/JVI.76.11.5305-5314.2002","article-title":"Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-l-arabinofuranosyl)-uracil (l-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection","volume":"76","author":"Menne","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.021_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2003.50154","article-title":"Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection","volume":"37","author":"Wang","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.021_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jmv.20019","article-title":"Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection","volume":"72","author":"Wang","year":"2004","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.021_bib13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/135965350400900611","article-title":"Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection","volume":"9","author":"Korba","year":"2004","journal-title":"Antivir Ther"},{"issue":"23","key":"10.1016\/j.vaccine.2008.05.021_bib14","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2174\/092986706778521995","article-title":"Treating chronic hepatitis B: today and tomorrow","volume":"13","author":"Borgia","year":"2006","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/314828","article-title":"Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens","volume":"180","author":"Couillin","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.021_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0168-8278(01)00028-9","article-title":"Efficacy and limitations of a specific immunotherapy in chronic hepatitis B","volume":"34","author":"Pol","year":"2001","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.021_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-96-5-575","article-title":"Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen","volume":"96","author":"Dienstag","year":"1982","journal-title":"Ann Intern Med"},{"issue":"8964","key":"10.1016\/j.vaccine.2008.05.021_bib18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91126-X","article-title":"Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy","volume":"345","author":"Wen","year":"1995","journal-title":"Lancet"},{"issue":"29\/30","key":"10.1016\/j.vaccine.2008.05.021_bib19","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/S0264-410X(02)00309-2","article-title":"Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers","volume":"20","author":"Jung","year":"2002","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2008.05.021_bib20","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.1128\/JVI.00691-07","article-title":"Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein","volume":"81","author":"Menne","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.05.021_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.05.021_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.021_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/14760584.5.5.707","article-title":"Therapeutic vaccination in chronic hepatitis B virus carriers","volume":"5","author":"Pol","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.021_bib24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/hum.1995.6.11-1447","article-title":"DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein","volume":"6","author":"Davis","year":"1995","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.021_bib25","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1128\/JVI.69.10.5929-5934.1995","article-title":"Nucleic acid vaccination primes hepatitis B virus surface antigen- specific cytotoxic T lymphocytes in nonresponder mice","volume":"69","author":"Schirmbeck","year":"1995","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.021_bib26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0264-410X(95)00255-Y","article-title":"DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost","volume":"14","author":"Davis","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.021_bib27","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.4049\/jimmunol.156.10.3687","article-title":"DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice","volume":"156","author":"Kuhrober","year":"1996","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.021_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/intimm\/9.8.1203","article-title":"DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes","volume":"9","author":"Kuhrober","year":"1997","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.021_bib29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/intimm\/dxg117","article-title":"HBsAg\/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection","volume":"15","author":"Loirat","year":"2003","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/JVI.01505-07","article-title":"Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections","volume":"82","author":"Depla","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.021_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/viro.1997.8942","article-title":"In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen","volume":"240","author":"Le Borgne","year":"1998","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.021_bib32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.20408","article-title":"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers","volume":"40","author":"Mancini-Bourgine","year":"2004","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.vaccine.2008.05.021_bib33","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.vaccine.2005.08.013","article-title":"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers","volume":"24","author":"Mancini-Bourgine","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.021_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.gt.3302751","article-title":"Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study","volume":"13","author":"Yang","year":"2006","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.021_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.021_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00063030-200418030-00002","article-title":"Electroporation for gene transfer to skeletal muscles: current status","volume":"18","author":"McMahon","year":"2004","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.021_bib37","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"issue":"27\/28","key":"10.1016\/j.vaccine.2008.05.021_bib38","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1016\/S0264-410X(02)00269-4","article-title":"Electroporation improves the efficacy of DNA vaccines in large animals","volume":"20","author":"Babiuk","year":"2002","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.05.021_bib39","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.021_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2005.08.093","article-title":"Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccination","volume":"24","author":"Zhao","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.021_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ilar.42.2.89","article-title":"The woodchuck model of hepatitis B virus infection","volume":"42","author":"Tennant","year":"2001","journal-title":"ILAR J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3748\/wjg.v13.i1.104","article-title":"The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection","volume":"13","author":"Menne","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.021_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/JVI.60.3.895-901.1986","article-title":"Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen","volume":"60","author":"Cote","year":"1986","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0042-6822(88)90389-3","article-title":"Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome","volume":"162","author":"Cohen","year":"1988","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.021_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/hep.510310128","article-title":"Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection","volume":"31","author":"Cote","year":"2000","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.021_bib46","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/IAI.71.12.6689-6692.2003","article-title":"Review of the use of statistics in infection and immunity","volume":"71","author":"Olsen","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.021_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2008.05.021_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0020-7519(03)00056-0","article-title":"Technical and regulatory hurdles for DNA vaccines","volume":"33","author":"Donnelly","year":"2003","journal-title":"Int J Parasitol"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2008.05.021_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08830180600743008","article-title":"DNA vaccination: a simple concept with challenges regarding implementation","volume":"25","author":"Babiuk","year":"2006","journal-title":"Int Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.021_bib50","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.7.11.1647","article-title":"Electroporation based DNA immunization: translation to the clinic","volume":"7","author":"Luxembourg","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2008.05.021_bib51","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(00)00476-X","article-title":"Immunization of livestock with DNA vaccines: current studies and future prospects","volume":"19","author":"van Drunen Littel-van den Hurk","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.021_bib52","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"Andre","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.05.021_bib53","first-page":"197","article-title":"Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA","volume":"94","author":"Graf","year":"2004","journal-title":"Methods Mol Med"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.021_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.gt.3302184","article-title":"Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3\/4A gene","volume":"11","author":"Frelin","year":"2004","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.021_bib55","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2004.08.027","article-title":"Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL\/6 mice","volume":"23","author":"Steinberg","year":"2005","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2008.05.021_bib56","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2007.07.025","article-title":"Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus","volume":"25","author":"Ternette","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.021_bib57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.021_bib58","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jgm.941","article-title":"DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity","volume":"8","author":"Kim","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2008.05.021_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2008.03.064","article-title":"Potentiation of an anthrax DNA vaccine with electroporation","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.021_bib60","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.165.5.2850","article-title":"Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice","volume":"165","author":"Dupuis","year":"2000","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.05.021_bib61","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1128\/JVI.74.24.11598-11607.2000","article-title":"Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer","volume":"74","author":"Zucchelli","year":"2000","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.021_bib62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3083.2003.01218.x","article-title":"DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants","volume":"57","author":"Tollefsen","year":"2003","journal-title":"Scand J Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.05.021_bib63","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.vaccine.2003.11.073","article-title":"Enhancement of DNA vaccine potency in rhesus macaques by electroporation","volume":"22","author":"Otten","year":"2004","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.05.021_bib64","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1016\/j.vaccine.2005.08.017","article-title":"Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation","volume":"24","author":"Otten","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.021_bib65","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.4049\/jimmunol.177.10.7462","article-title":"Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates","volume":"177","author":"Capone","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.021_bib66","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"Luckay","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:52:49Z","timestamp":1684428769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":66,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}